Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Effect of aspirin resistance with dyslipidemia against VerifyNOW® measurement in Bethesda hospital Yogyakarta

Jurnal kedokteran dan kesehatan Indonesia · Vol. 7 No. 2 (2015) · hlm. 41–45

DOI
10.20885/jkki.vol7.iss2.art2
ISSN
2085-4145, 2527-2950
Terbit
2015-09-20
Penerbit
Islamic University of Indonesia
Bahasa
en
Lisensi
creativecommons.org/licenses/by/4.0/

Abstrak

Background: Aspirin is first line drug of choice to prevent ischemic stroke. However, some cases are found occuring of aspirin resistance. Objective: This study was to examine the effect of dyslipidemia on the risk of antiplatelet resistance with VerifyNOW ® at Bethesda Hospital Yogyakarta. Method: This research was observational analysis using a nested casecontrol study design. The subjects were ischemic stroke patients who underwent tests of platelet function by VerifyNOW® (Accumetrics, San Diego, CA, USA). The Case group was ischemic stroke patients who has history of aspirin resistance. The control group was ischemic stroke patients who response on aspirin therapy. Both groups were analyzed and compared to the state of dyslipidemia. Results: Bivariate analysis on the incidence of aspirin resistance indicate that dyslipidemia had OR = 0.979 (95% CI; 0.378 to 2.531), p = 0.572. Hypercholesterolemia had OR = 0,909 (CI 95%; 0,377-2,190) p = 0,500; hypertrigliceride had OR = 0,838 (CI 95%; 0,331-2,119) p = 0,409; abnormal HDL had OR = 1,468 (CI 95% 0,564-3,817) p = 0,238; abnormal LDL had OR = 0,937 (CI 95% 0,374-2,345) p = 0,500. Patient factors such as age >55 years (p = 0.168) and female gender (p = 0.226) showed a nonsignificant results. Conclusion: Ischemic stroke patients at Bethesda Hospital Yogyakarta who had dyslipidemia were not evident to have a greater risk of aspirin resistance than ischemic stroke patients who did not undergo dyslipidemia.

Kata kunci

Jaringan kolaborasi para penulis

24 penulis · 45 tautan kepenulisan bersama · 24 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Duta Wacana Christian University
  • Universitas Gadjah Mada
  • Bethesda Hospital
  • Universitas Ahmad Dahlan
  • State University of Semarang
  • Muhammadiyah University of Surakarta
  • Islamic University of Indonesia
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sugianto SugiantoState University of Semarang2
Esdras Ardi PramuditaDuta Wacana Christian University2
Rosa De Lima Renita SanyasiAfiliasi tidak diketahui2
Andre Dharmawan WijonoAfiliasi tidak diketahui1
Renita, Rosa De LimaAfiliasi tidak diketahui1
Hanshel Everad NathanaelDuta Wacana Christian University1
EM SutrisnaMuhammadiyah University of Surakarta1
Iwan DwiprahastoUniversitas Gadjah Mada1
Laksmi AsantiBethesda Hospital1
Kriswanto WidyoBethesda Hospital1
Lucas MelialaUniversitas Gadjah Mada1
Sri SutarniAfiliasi tidak diketahui1
Fransiska Theresia Meivy BabangDuta Wacana Christian University1
Ari WibowoIndonesian Coffee and Cocoa Research Institute1
Dwi Aris Agung NugrahaningsihUniversitas Gadjah Mada1
Mustofa MustofaUniversitas Gadjah Mada1
Akhmad Kharis NugrohoUniversitas Gadjah Mada1
Dimas Adhi PradanaIslamic University of Indonesia1
Daniel Mahendra KrisnaDuta Wacana Christian University1
HariatmokoBethesda Hospital1
Aditya BatlajeryDuta Wacana Christian University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210214198, pertama di-harvest 20 Nov 2026, terakhir terlihat 20 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Effect of aspirin resistance with dyslipidemia against VerifyNOW® measurement in Bethesda hospital Yogyakarta</dc:title><dc:creator>Hardi Astuti Witasari</dc:creator><dc:creator>Rizaldy Taslim Pinzon</dc:creator><dc:creator>Erna Kristin</dc:creator><dc:subject>aspirin resistance</dc:subject><dc:subject>dyslipidemia</dc:subject><dc:subject>ischemic stroke</dc:subject><dc:subject>antiplatelet therapy</dc:subject><dc:subject>hypercholesterolemia</dc:subject><dc:subject>hypertriglyceridemia</dc:subject><dc:subject>ischemic stroke risk factors</dc:subject><dc:description xml:lang="en">Background: Aspirin is first line drug of choice to prevent ischemic stroke. However, some cases are found occuring of aspirin resistance. Objective: This study was to examine the effect of dyslipidemia on the risk of antiplatelet resistance with VerifyNOW ® at Bethesda Hospital Yogyakarta. Method: This research was observational analysis using a nested casecontrol study design. The subjects were ischemic stroke patients who underwent tests of platelet function by VerifyNOW® (Accumetrics, San Diego, CA, USA). The Case group was ischemic stroke patients who has history of aspirin resistance. The control group was ischemic stroke patients who response on aspirin therapy. Both groups were analyzed and compared to the state of dyslipidemia. Results: Bivariate analysis on the incidence of aspirin resistance indicate that dyslipidemia had OR = 0.979 (95% CI; 0.378 to 2.531), p = 0.572. Hypercholesterolemia had OR = 0,909 (CI 95%; 0,377-2,190) p = 0,500; hypertrigliceride had OR = 0,838 (CI 95%; 0,331-2,119) p = 0,409; abnormal HDL had OR = 1,468 (CI 95% 0,564-3,817) p = 0,238; abnormal LDL had OR = 0,937 (CI 95% 0,374-2,345) p = 0,500. Patient factors such as age &gt;55 years (p = 0.168) and female gender (p = 0.226) showed a nonsignificant results. Conclusion: Ischemic stroke patients at Bethesda Hospital Yogyakarta who had dyslipidemia were not evident to have a greater risk of aspirin resistance than ischemic stroke patients who did not undergo dyslipidemia.</dc:description><dc:publisher>Islamic University of Indonesia</dc:publisher><dc:date>2015-09-20</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20885/jkki.vol7.iss2.art2</dc:identifier><dc:identifier>10.20885/jkki.vol7.iss2.art2</dc:identifier><dc:source>Jurnal kedokteran dan kesehatan Indonesia; Vol 7 No 2 (2015); 41-45</dc:source><dc:source>2085-4145</dc:source><dc:source>2527-2950</dc:source><dc:language>en</dc:language><dc:relation>https://journal.uii.ac.id/JKKI/article/view/4500/3970</dc:relation><dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights></oai_dc:dc>